Zdrowie i gospodarka · 14/04/2020
FDA Announces Final Guidances for Chloroquine Phosphate and Hydroxychloroquine Sulfate
The US Food and Drug Administration (FDA) has released final guidances for the pharmaceutical industry on product-specific recommendations for chloroquine phosphate and hydroxychloroquine sulfate, which include bioequivalence study designs for abbreviated new drug applications (ANDAs)
Source: Federal Register — Food and Drug AdministrationOpen original release →